OTRIVIN PEDIATRIC NASAL SPRAY 0.05% .05 %
XYLOMETAZOLINE HYDROCHLORIDE : .05 % · DIN 00623466 · NOVARTIS CONSUMER HEALTH CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is OTRIVIN PEDIATRIC NASAL SPRAY 0.05%?
OTRIVIN PEDIATRIC NASAL SPRAY 0.05% .05 % contains XYLOMETAZOLINE HYDROCHLORIDE : .05 %. It is listed in the Health Canada Drug Product Database under DIN 00623466, held by NOVARTIS CONSUMER HEALTH CANADA INC., supplied as SPRAY for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 21-Jul-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00623466 |
|---|---|
| Brand name | OTRIVIN PEDIATRIC NASAL SPRAY 0.05% |
| Generic / active ingredient | XYLOMETAZOLINE HYDROCHLORIDE : .05 % |
| Manufacturer | NOVARTIS CONSUMER HEALTH CANADA INC. |
| Strength | .05 % |
| Dosage form | SPRAY |
| Route of administration | NASAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01AA07 XYLOMETAZOLINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 21-Jul-1999 |
What can be used instead?
Other Canadian products sharing ATC code R01AA07 XYLOMETAZOLINE. 5 of 31 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DECONGESTANT NASAL SPRAY | 0.1 % | SPRAY | CRLS | MARKETED | DIN 02452812 |
| NASAL DECONGESTANT SPRAY WITH MOISTURIZERS | 0.1 % | SPRAY | CRLS | MARKETED | DIN 02452863 |
| OTRIVIN MEDICATED COLD & ALLERGY RELIEF | 0.1 % | SPRAY | HALEON CANADA ULC | MARKETED | DIN 00653330 |
| OTRIVIN MEDICATED COLD & ALLERGY RELIEF WITH MOISTURIZERS | 0.1 % | SPRAY | HALEON CANADA ULC | MARKETED | DIN 02208903 |
| OTRIVIN MEDICATED COMPLETE NASAL CARE | 0.1 % | SPRAY | HALEON CANADA ULC | MARKETED | DIN 02331403 |
| BALMINIL DECONGEST | 0.1 % | SOLUTION | TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02300257 |
| BALMINIL NASAL DECONGESTANT | 0.1 % | SPRAY | TEVA CANADA LIMITED | DORMANT | DIN 00791172 |
| CERTIFIED DECONGESTANT NASAL SPRAY .1% | 0.1 % | SPRAY ; SOLUTION | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 02054701 |
| COLD & ALLERGY RELIEF | 0.1 % | SPRAY | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02246021 |
| COLD & ALLERGY RELIEF WITH MOISTURIZERS | 0.1 % | SPRAY | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02246023 |
Who else supplies XYLOMETAZOLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. XYLOMETAZOLINE appears in 2706 registered pack listings across 5 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.